Vial Provider Comparison
Defy Medical vs Direct Peptides
Same category. Different operational transparency.
Defy Medical
Telehealth PlatformVIAL REVIEWED
75/ 100
Vial Trust Score
Direct Peptides
Grey Market VendorUSE CAUTION
65/ 100
Vial Trust Score
SignalDefy MedicalDirect Peptides
Pharmacy Disclosure
Do they name their pharmacy partner?
✓Names its pharmacy partner
✕No pharmacy partner named
Physician Oversight
Are prescribing clinicians named?
✓Named clinical leadership
✕No clinician disclosure
Pricing Transparency
Is pricing shown before signup?
✓Public pricing (Mid)
✓Public pricing (Premium)
Federal Enforcement History
Any FDA, DEA, or OIG actions?
✓No federal actions found
✓No federal actions found
State Availability
How widely is care available?
✓48 states
✓Available in all 50 states
Membership Model
Is a paid membership required?
✓No membership required
✓No membership required
Data & Privacy
Any reported HIPAA breaches?
✓No breaches on record
✓No breaches on record
More disclosure
Defy Medical
Discloses more across pharmacy disclosure and physician oversight.
Less disclosure
Direct Peptides
Gaps in pharmacy disclosure and physician oversight.
Updated May 26, 2026
Scores based on operational, compliance, and transparency signals tracked by Vial.
Found this helpful? Share it.
Help others get informed.
Other matchups
Related comparisons
75Defy Medical
81LifeForce
6-point gapSee the gap →
65Direct Peptides
66Empower Pharmacy
1-point gapSee the gap →
75Defy Medical
80Marek Health
5-point gapSee the gap →
65Direct Peptides
70Hone Health
5-point gapSee the gap →
75Defy Medical
70Hone Health
5-point gapSee the gap →
65Direct Peptides
58Tailstorm Health, Inc. [dba Medivant]
7-point gapSee the gap →